NV
VIGL

Northpond Ventures’s Vigil Neuroscience VIGL Stock Holding History

Northpond Ventures’s Portfolio VIGL Stock Details VIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$14.3M Hold
4,214,498
– – 32.82% 2
2024
Q2 		$16.9M Hold
4,214,498
– – 30.5% 2
2024
Q1 		$14.4M Hold
4,214,498
– – 14% 2
2023
Q4 		$14.2M Hold
4,214,498
– – 67.78% 1
2023
Q3 		$22.7M Hold
4,214,498
– – 65.4% 1
2023
Q2 		$39.6M Hold
4,214,498
– – 65.75% 1
2023
Q1 		$41.3M Hold
4,214,498
– – 23.58% 2
2022
Q4 		$52.7M Hold
4,214,498
– – 28.58% 2
2022
Q3 		$38.4M Hold
4,214,498
– – 26.88% 2
2022
Q2 		$10.9M Hold
4,214,498
– – 10.36% 4
2022
Q1 		$29.6M Buy
+4,214,498
New +$55.6M 15.97% 4

Other funds holding VIGL

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return

Northpond Ventures's VIGL Position: Q3 2024 in Review

Northpond Ventures held its Vigil Neuroscience (VIGL) position steady in Q3 2024 at 4,214,498 shares worth $14.3M. The position accounts for 32.82% of the portfolio, ranked #2.

Northpond Ventures first reported a position in VIGL in Q1 2022 and has held it in 11 quarters since. The position peaked at $52.7M in Q4 2022. 52 funds tracked by Wall St. Rank hold VIGL as of Q3 2024.

  • Northpond Ventures held 4,214,498 shares of Vigil Neuroscience worth $14.3M as of Q3 2024.
  • Northpond Ventures left its Vigil Neuroscience share count unchanged in Q3 2024.
  • Vigil Neuroscience made up 32.82% of Northpond Ventures's portfolio in Q3 2024, its #2 holding.
  • Northpond Ventures first reported a position in Vigil Neuroscience in Q1 2022 and has held it in 11 quarters since.
  • Northpond Ventures's Vigil Neuroscience position peaked at $52.7M in Q4 2022.
  • 52 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q3 2024.

Based on Northpond Ventures's 13F filing for Q3 2024, filed 14 Nov 2024.